Lupin Gets U.S. FDA Approval For Skin  Cream
A packaging unit at the Lupin pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

Lupin Gets U.S. FDA Approval For Skin Cream


Drugmaker Lupin Ltd. on Friday said it has received approval from the U.S. health regulator for generic Hydrocortisone Valerate cream used for relief from inflammation and itching due to various skin conditions.

The company has got approval for its Hydrocortisone Valerate cream USP, 0.2 percent from the United States Food and Drug Administration, Lupin said in an exchange filing.

The product is generic version of Sun Pharmaceutical Industries Ltd.’s Westcort cream in the same strength, it added.

The cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients, Lupin said.

Shares of Lupin Ltd. on Friday ended at Rs 729.40 per scrip on the Bombay Stock Exchange, down 0.67 percent from its previous close.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.